Relief Cardiovascular is focused on developing transcatheter smart implant systems to enhance volume management in heart failure, particularly for diuretic-resistant patients
Relief Cardiovascular is focused on developing transcatheter smart implant systems to enhance volume management in heart failure, particularly for diuretic-resistant patients. Their Relief System is the world's first transcatheter preload modulating implant that enables autonomous hemodynamic monitoring and modulation of venous return.